Form 4: Cerus Corp Executive Richard J. Benjamin Sells 29,378 Shares

Richard J. Benjamin, Chief Medical Officer of Cerus Corporation, sold 29,378 shares of common stock at an average price of $2.3983 on March 8, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On March 8, 2024, Richard J. Benjamin, the Chief Medical Officer of Cerus Corporation, sold 29,378 shares of Cerus Corp (CERS) common stock.
• The sale was executed at a weighted average price of $2.3983 per share.
• The transactions occurred under a pre-arranged 10b5-1 trading plan.
• Following the sale, Benjamin directly owns 478,061 shares of Cerus Corp.
• The price range for the shares sold was between $2.34 and $2.46, inclusive.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of a stock sale by an executive, which is neither inherently positive nor negative. The sale was conducted under a pre-arranged 10b5-1 plan, suggesting it was planned in advance and not necessarily indicative of the executive's current sentiment about the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders buy or sell their company's stock. These filings are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
• The sale does not appear to directly impact employees, customers, suppliers, or creditors.

Key Dates